ZA885249B - Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols - Google Patents

Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols

Info

Publication number
ZA885249B
ZA885249B ZA885249A ZA885249A ZA885249B ZA 885249 B ZA885249 B ZA 885249B ZA 885249 A ZA885249 A ZA 885249A ZA 885249 A ZA885249 A ZA 885249A ZA 885249 B ZA885249 B ZA 885249B
Authority
ZA
South Africa
Prior art keywords
conjugates
coupled
molecular weight
high molecular
superoxide dismutase
Prior art date
Application number
ZA885249A
Other languages
English (en)
Inventor
Mark Saifer
Saifer Mark
Ralph Somack
Somack Ralph
L David Williams
David Williams L
Original Assignee
Ddi Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ddi Pharmaceuticals filed Critical Ddi Pharmaceuticals
Publication of ZA885249B publication Critical patent/ZA885249B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
    • C12N11/089—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA885249A 1987-08-03 1988-07-20 Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols ZA885249B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8100987A 1987-08-03 1987-08-03

Publications (1)

Publication Number Publication Date
ZA885249B true ZA885249B (en) 1989-04-26

Family

ID=22161332

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA885249A ZA885249B (en) 1987-08-03 1988-07-20 Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols

Country Status (17)

Country Link
EP (1) EP0377613B1 (xx)
JP (1) JP2515389B2 (xx)
KR (1) KR920001426B1 (xx)
CN (1) CN1020458C (xx)
AU (1) AU608901B2 (xx)
CA (1) CA1309046C (xx)
DE (1) DE3876997T2 (xx)
DK (1) DK160842C (xx)
ES (1) ES2007536A6 (xx)
HU (1) HU203783B (xx)
IE (1) IE64284B1 (xx)
IL (1) IL87177A (xx)
NZ (1) NZ225481A (xx)
PH (1) PH27225A (xx)
RU (1) RU1776275C (xx)
WO (1) WO1989001033A1 (xx)
ZA (1) ZA885249B (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0893439B1 (en) * 1989-04-19 2005-07-27 Enzon, Inc. A process for forming a modified polypeptide comprising a polypeptide and a polyalkylene oxide
US5109118A (en) * 1989-07-06 1992-04-28 Yutaka Mizushima Modified biologically active proteins
GB8919661D0 (en) * 1989-08-31 1989-10-11 Univ Alberta Superoxide dismutase-catalase conjugates
US5772996A (en) * 1990-08-03 1998-06-30 Public Health Laboratory Service Board Pharmaceutical compositions containing superoxide dismutase from Bacillus Stearothermophilus and Bacillus Caldotenax
WO1993002701A1 (en) * 1991-08-05 1993-02-18 Sterling Winthrop Inc. Buffered formulation of peg-sod
FR2687681B1 (fr) * 1992-02-20 1995-10-13 Transgene Sa Conjugues polyethyleneglycol-hirudine, leur procede de preparation et leur emploi pour le traitement des thromboses.
US5349001A (en) * 1993-01-19 1994-09-20 Enzon, Inc. Cyclic imide thione activated polyalkylene oxides
US5516703A (en) * 1993-08-20 1996-05-14 The University Of Utah Coating of hydrophobic surfaces to render them protein resistant while permitting covalent attachment of specific ligands
US6284503B1 (en) 1993-08-20 2001-09-04 University Of Utah Research Foundation Composition and method for regulating the adhesion of cells and biomolecules to hydrophobic surfaces
WO1999067370A1 (en) * 1998-06-23 1999-12-29 Novozymes A/S A polypeptide-polymer conjugate
US6638526B1 (en) 1998-06-23 2003-10-28 Novozymes A/S Polypeptides conjugated to copolymers of ethylene oxide and propylene oxide to reduce allergenicity
JP2002520049A (ja) * 1998-07-17 2002-07-09 ノボザイムス アクティーゼルスカブ 改良された洗浄性能を有するポリペプチド−ポリマー接合体
US8129330B2 (en) 2002-09-30 2012-03-06 Mountain View Pharmaceuticals, Inc. Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
US20040062748A1 (en) 2002-09-30 2004-04-01 Mountain View Pharmaceuticals, Inc. Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
BR0317742A (pt) 2002-12-26 2005-11-22 Mountain View Pharmaceuticals Conjugados poliméricos de interferon-beta com potência biológica aumentada
EP1626983B8 (en) 2003-05-12 2010-12-22 Affymax, Inc. Novel poly (ethylene glycol) modified erythropoietin agonists and uses thereof
CN108445106A (zh) * 2018-04-11 2018-08-24 南京明捷生物医药检测有限公司 一种药物中消泡剂聚丙二醇残留的检测方法
CN108864309B (zh) * 2018-07-26 2021-07-13 广州暨南大学医药生物技术研究开发中心有限公司 重组人sod-生长因子融合蛋白、其制备方法及其应用
CN109112119B (zh) * 2018-08-28 2022-04-26 佛山科学技术学院 经化学修饰的鸭血sod制剂的制备方法
CN117551625B (zh) * 2024-01-12 2024-03-08 山东爱维德生物科技有限公司 一种用于木立芦荟sod胶的聚乙二醇二胺-海藻酸改性sod酶及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL74177A (en) * 1984-02-03 1989-09-10 Abbott Lab Stabilized enzyme conjugate composition containing a calcium salt and a polyethylene glycol
GB8430252D0 (en) * 1984-11-30 1985-01-09 Beecham Group Plc Compounds
GB8430253D0 (en) * 1984-11-30 1985-01-09 Beecham Group Plc Compounds
JPH084504B2 (ja) * 1985-04-26 1996-01-24 味の素株式会社 安定化ス−パ−オキサイドジスムタ−ゼ

Also Published As

Publication number Publication date
WO1989001033A1 (en) 1989-02-09
JPH02504341A (ja) 1990-12-13
DK160842C (da) 1991-10-14
HUT52816A (en) 1990-08-28
KR920001426B1 (ko) 1992-02-13
IE882206L (en) 1989-02-03
DE3876997T2 (de) 1993-04-29
AU608901B2 (en) 1991-04-18
DE3876997D1 (de) 1993-02-04
NZ225481A (en) 1990-11-27
CN1020458C (zh) 1993-05-05
RU1776275C (ru) 1992-11-15
DK160842B (da) 1991-04-22
DK392789D0 (da) 1989-08-10
KR890701736A (ko) 1989-12-21
EP0377613B1 (en) 1992-12-23
AU2326888A (en) 1989-03-01
PH27225A (en) 1993-05-04
IL87177A0 (en) 1988-12-30
IL87177A (en) 1992-08-18
JP2515389B2 (ja) 1996-07-10
IE64284B1 (en) 1995-07-26
HU203783B (en) 1991-09-30
CA1309046C (en) 1992-10-20
EP0377613A1 (en) 1990-07-18
CN1031088A (zh) 1989-02-15
ES2007536A6 (es) 1989-06-16
DK392789A (da) 1989-08-10

Similar Documents

Publication Publication Date Title
PH27225A (en) Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols
IL86671A (en) Conjugates of hyaluronic acid and their preparation
NZ224275A (en) Low molecular weight heparin derivatives; pharmaceutical compositions
BG47944A3 (en) Design of road track for mobile toys
HK1014674A1 (en) Cell binding agent conjugates of derivatives of cc-1065
EP0200467A3 (en) Superoxide dismutase combined with a poly(alkylene oxide)
EP0296445A3 (en) Improvements to air springs
HK115594A (en) High molecular weight polystyrene blends with PPE and hips
GB8712520D0 (en) Conveying supporting & shaping glass sheets
IL79929A0 (en) Expression of superoxide dismutase
IT8948157A0 (it) Composizione di superossido dismutasi
IL87880A (en) Covalent oligonucleotide- horseradish peroxidase conjugates and their preparation
GB8919661D0 (en) Superoxide dismutase-catalase conjugates
GB8601128D0 (en) Imparting movement to baby cradle
EP0292321A3 (en) Acylated derivative of superoxide dismutase and composition containing same
GB2055373B (en) Preparation of vicinal alkylene glycols
GB2207352B (en) Use of papaverine in formulating anti-viral compositions
GB8613315D0 (en) Preparing conjugates of metalloproteins
IL71689A0 (en) Human superoxide dismutase production
ZA881743B (en) Human manganese superoxide dismutase(hmn-sod)
PL263081A1 (en) Mobile trackway to autoclave
GB8806664D0 (en) Improvements in/relating to trolleys for supporting missiles
IE873096L (en) Preparation of low molecular weight glucosaminoglycans
GB9026229D0 (en) Tolerogenic conjugates for suppressing immune responses
GR871647B (en) Personal flat pocket glass